Why the study?
Does off-pump coronary artery bypass surgery with the Octopus Tissue Stabilizer improve safety and efficacy compared to conventional on-pump coronary artery bypass surgery?
Does off-pump coronary artery bypass surgery with the Octopus Tissue Stabilizer improve safety and efficacy compared to conventional on-pump coronary artery bypass surgery?
The evidence base for off-pump CABG using the Octopus Tissue Stabilizer is inadequate to determine its efficacy compared to conventional on-pump CABG, though safety appears similar.
Answers are grounded in this paper and cite their sources.
Insufficient evidence to guide Octopus OPCAB versus CPB-CABG selection; leaves open efficacy assessment pending randomized trials.
The safety and efficacy of off-pump coronary artery bypass surgery with the aid of the Octopus Tissue Stabilizer (Octopus OPCAB), in comparison to conventional on-pump coronary artery bypass surgery (CPB-CABG), was examined by a systematic assessment of the peer-reviewed literature. The limited comparative data suggested that there was no difference in safety outcomes between Octopus OPCAB and CPB-CABG. The paucity of efficacy data reported in the higher level comparative studies meant that it was impossible to assess whether Octopus OPCAB was more efficacious than CPB-CABG. The evidence base for the procedure was deemed inadequate and an audit of the procedure was recommended.
No takes yet. Share an insight, caveat, or question.
N. Ann Scott (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: